<DrugInformationSummary id="CDR0000801469"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Tucatinib works by binding to the part of the HER2 protein that is inside the cell, preventing it from sending signals that promote cell growth. It is a type of targeted therapy drug called a tyrosine kinase inhibitor. It is a small-molecule drug (a drug that can enter cells easily).</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/tucatinib">Tucatinib</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000594366">tucatinib</TerminologyLink><GlossaryLink ref="CDR0000801446">tucatinib</GlossaryLink><USBrandNames><USBrandName>Tukysa</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>too-KA-tih-nib</TermPronunciation><MediaLink ref="CDR0000802700" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000802701" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f27eb1b9-b7fc-424e-988f-84dd7bb195a3&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Tucatinib</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f27eb1b9-b7fc-424e-988f-84dd7bb195a3&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Tucatinib
         is approved to treat adults whose cancer is <GlossaryTermRef href="CDR0000737998" dictionary="Cancer.gov" audience="Patient">HER2 positive</GlossaryTermRef>, including:</Para>                          
  
  <ItemizedList Style="bullet" id="_5"><ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">Breast cancer</GlossaryTermRef></Strong> that  cannot be removed by surgery or has spread to other parts of the body, such as the <GlossaryTermRef href="CDR0000797669" dictionary="Cancer.gov" audience="Patient">brain</GlossaryTermRef>. It is used  with <GlossaryTermRef href="CDR0000045439" dictionary="Cancer.gov" audience="Patient">trastuzumab</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045565" dictionary="Cancer.gov" audience="Patient">capecitabine</GlossaryTermRef> in patients who have received at least one anti-HER2 treatment for cancer that has spread to other parts of the body.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000444983" dictionary="Cancer.gov" audience="Patient">Colorectal cancer</GlossaryTermRef></Strong> that  cannot be removed by surgery or has spread to other parts of the body and has the <GlossaryTermRef href="CDR0000790142" dictionary="Cancer.gov" audience="Patient">wild-type</GlossaryTermRef> <GeneName><GlossaryTermRef href="CDR0000045859" dictionary="Cancer.gov" audience="Patient">RAS</GlossaryTermRef></GeneName> gene. It is used with trastuzumab in patients who have received treatment that included a <GlossaryTermRef href="CDR0000386207" dictionary="Cancer.gov" audience="Patient">fluoropyrimidine</GlossaryTermRef>,
<GlossaryTermRef href="CDR0000045465" dictionary="Cancer.gov" audience="Patient">oxaliplatin</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000635811" dictionary="Cancer.gov" audience="Patient">irinotecan hydrochloride</GlossaryTermRef> and it did not work or is no longer working.¹</ListItem></ItemizedList><Para id="_6">¹This use is approved under FDA’s <ExternalRef xref="https://www.fda.gov/ForPatients/Approvals/Fast/ucm405447.htm">Accelerated Approval Program</ExternalRef>. As a condition of approval, a <GlossaryTermRef href="CDR0000799146" dictionary="Cancer.gov" audience="Patient">confirmatory trial(s)</GlossaryTermRef> must show that tucatinib provides a clinical benefit in these patients.</Para><Para id="_4">Tucatinib
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Tucatinib</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/594366">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.27">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a620032.html">Tucatinib</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.28"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.29">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2023/fda-tucatinib-her2-colorectal-cancer">Tucatinib and Trastuzumab Combination Approved for Advanced Colorectal Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C77896">Find Clinical Trials for Tucatinib</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2020-05-05</DateFirstPublished><DateLastModified>2024-12-13</DateLastModified></DrugInformationSummary>
